Professional
Added to YB: 2025-01-17
Pitch date: 2025-01-16
PRCT [bearish]
PROCEPT BioRobotics Corporation
+54.59%
current return
Author Info
Spruce Point Capital Management is an activist investment manager specializing in forensic short-selling. Sign up for the newsletter.
Company Info
PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally.
Market Cap
$3.7B
Pitch Price
$79.26
Price Target
29.00 (-19%)
Dividend
N/A
EV/EBITDA
-37.64
P/E
-34.68
EV/Sales
17.73
Sector
Health Care Equipment and Supplies
Category
N/A
Spruce Point Capital Management Issues 'Strong Sell' Research Opinion PROCEPT BioRobotics (Nasdaq: PRCT)
PRCT: Aquablation for BPH overhyped. Addressable market smaller than claimed, growth barriers (urologist capacity, hospital penetration). Rising DSOs, inventory concerns. MISTs superior for smaller prostates. Valuation absurd at 14x 2025E revenue. $29-$54 price target (30-60% downside).
Read full article (30 min)